|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001779,
umls-concept:C0006142,
umls-concept:C0024202,
umls-concept:C0030705,
umls-concept:C0279781,
umls-concept:C0439234,
umls-concept:C0918012,
umls-concept:C1282910,
umls-concept:C1334779,
umls-concept:C1514485,
umls-concept:C1522673
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2011-3-1
|
|
pubmed:abstractText |
In breast cancer, different tools are used for prognostication and adjuvant systemic therapy selection. We compared the accuracy of the online program Adjuvant!, the Norwegian Breast Cancer Group (NBCG) guidelines, and the proliferation factor mitotic activity index (MAI) in patients with lymph node (LN) -negative disease (pN0).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
852-8
|
|
pubmed:meshHeading |
pubmed-meshheading:21189388-Adult,
pubmed-meshheading:21189388-Age Factors,
pubmed-meshheading:21189388-Biopsy, Needle,
pubmed-meshheading:21189388-Breast Neoplasms,
pubmed-meshheading:21189388-Chemotherapy, Adjuvant,
pubmed-meshheading:21189388-Cohort Studies,
pubmed-meshheading:21189388-Disease-Free Survival,
pubmed-meshheading:21189388-Female,
pubmed-meshheading:21189388-Humans,
pubmed-meshheading:21189388-Immunohistochemistry,
pubmed-meshheading:21189388-Lymph Nodes,
pubmed-meshheading:21189388-Lymphatic Metastasis,
pubmed-meshheading:21189388-Middle Aged,
pubmed-meshheading:21189388-Mitotic Index,
pubmed-meshheading:21189388-Multivariate Analysis,
pubmed-meshheading:21189388-Neoplasm Invasiveness,
pubmed-meshheading:21189388-Patient Selection,
pubmed-meshheading:21189388-Prognosis,
pubmed-meshheading:21189388-Proportional Hazards Models,
pubmed-meshheading:21189388-Risk Assessment,
pubmed-meshheading:21189388-Statistics, Nonparametric,
pubmed-meshheading:21189388-Survival Analysis,
pubmed-meshheading:21189388-Treatment Outcome,
pubmed-meshheading:21189388-Tumor Markers, Biological
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
In patients younger than age 55 years with lymph node-negative breast cancer, proliferation by mitotic activity index is prognostically superior to adjuvant!
|
|
pubmed:affiliation |
Stavanger University Hospital, Stavanger, Norway.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
